9960 fundamentals
Key facts
Market capitalization—
Founded—
CEO—
Website—
About
Kindstar Globalgene Technology, Inc. is an investment holding company, which engages in the provision of clinical testing services. It operates through the following segments: Hematology Testing, Genetic Diseases and Rare Diseases, Infectious Diseases, Oncology, Neurology, Maternity-Related Diseases, COVID-19 Related Testing, Routine Testing, and Others. The Others segment includes testing services for research and development projects, and others and miscellaneous services. The company was founded on August 24, 2007 and is headquartered in Wuhan, China.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
9960 does not pay dividends
The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future
Financial health
Financial position and solvency of the company